{
  "id": 961709,
  "title": "Abacus global CEO Jay Jackson sells $1.7m in company stock",
  "url": "https://urgent.news/2026/08/15/abacus-global-ceo-jay-jackson-sells-1-7m-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-15T04:45:55.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/abacus-global-ceo-jay-jackson-sells-17m-in-company-stock-93CH-4861736"
  },
  "original_language": "en",
  "account": "Abacus Global Management CEO Jay J. Jackson sold 196,000 shares of the company's stock on August 12, 2026, transferring $1.7 million to satisfy tax obligations. The stock price fluctuated between $8.53 and $9.07 during the transactions, with an average sale price of $8.77 per share. Since the sale, Abacus Global stock has risen to $9.27, marking a 49% increase over the past year. Despite the stock's current value, InvestingPro data indicates it is still undervalued, with a Fair Value of $12.26, placing it on the list of most undervalued stocks. Following the sales, Jackson owned 10,397,430 shares of Abacus Global Management common stock. The company's recent second-quarter earnings exceeded Wall Street expectations, with adjusted earnings of $0.28 per share, surpassing the forecasted $0.2427 per share. Revenue for the quarter reached $73 million, a 30% increase compared to the previous year. Management attributed this growth to increased capital deployment and the success of new products. The company has maintained its full-year guidance as unchanged. These financial improvements have positively influenced the company's recent after-hours trading.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Edgewise Therapeutics CEO Kevin Koch sells $785,042 in stock",
        "url": "https://urgent.news/2026/08/15/edgewise-therapeutics-ceo-kevin-koch-sells-785-042-in-stock",
        "published": "2026-08-15T04:01:04.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}